AMD Invests $20M in Absci to Accelerate AI Drug Discovery
AMD invests $20M in Absci to boost AI drug discovery using AMD’s high-performance computing. This collaboration aims to accelerate Absci’s antibody design models, potentially revolutionizing biologics development and reducing drug discovery timelines.
AMD Invests $20M in Absci to Accelerate AI Drug Discovery Read More »